A Non-interventional Study for Relative Efficacy Outcome of Rituximab Treatment in RA Patients Who Have Inadequate Response or Have Been Intolerant to a First Anti-TNF Agent
Phase of Trial: Phase IV
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 26 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 23 May 2013 Planned end date changed from 1 Mar 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.